- Pulse Biosciences (PLSE) just hit a new 5-year high and has strong technical momentum.
- Shares are up more than 100% over the past 52 weeks.
- Revenue is projected to surge 652.38% this year and 236.71% next.
- Analyst sentiment is mixed, with ratings from “Strong Buy” to “Strong Sell,” reflecting its high valuation and lack of earnings.